Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$2.35
$1.94
$0.63
$2.44
$160.33M0.87358,220 shs200,291 shs
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$3.76
+1.6%
C$4.36
C$3.34
C$7.12
C$119.61M1.148,214 shs901 shs
Leaf Group Ltd. stock logo
LEAF
Leaf Group
$8.49
$8.47
$2.48
$9.50
$305.91M2.13959,348 shsN/A
Meredith Co. stock logo
MDP
Meredith
$58.78
$18.00
$59.16
$2.70B2.07552,848 shs3.36 million shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
0.00%+7.80%+31.28%+36.63%+248.72%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
-4.64%-6.09%-20.43%-7.04%-10.84%
Leaf Group Ltd. stock logo
LEAF
Leaf Group
0.00%0.00%0.00%0.00%0.00%
Meredith Co. stock logo
MDP
Meredith
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
2.1856 of 5 stars
3.55.00.00.03.20.00.0
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
0.4688 of 5 stars
1.10.01.70.03.22.50.0
Leaf Group Ltd. stock logo
LEAF
Leaf Group
N/AN/AN/AN/AN/AN/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
3.00
Buy$7.00198.51% Upside
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
2.25
HoldC$3.883.06% Upside
Leaf Group Ltd. stock logo
LEAF
Leaf Group
N/AN/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
N/AN/AN/AN/A

Current Analyst Ratings

Latest HLS, MDP, CRDL, and LEAF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/23/2024
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$6.00 ➝ $8.00
5/23/2024
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$6.00 ➝ $8.00
5/14/2024
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00
5/10/2024
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$5.00 ➝ C$4.00
5/10/2024
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$4.15 ➝ C$3.75
4/22/2024
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$9.00
3/18/2024
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$6.50 ➝ C$5.00
3/15/2024
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$4.35 ➝ C$4.15
(Data available from 5/28/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$60K2,672.13N/AN/A$0.32 per share7.33
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$60.79M1.97C$0.25 per share15.22C$2.77 per share1.36
Leaf Group Ltd. stock logo
LEAF
Leaf Group
$212.06M1.44$0.02 per share400.34$2.19 per share3.88
Meredith Co. stock logo
MDP
Meredith
$2.98B0.00N/A5.68$14.27 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$20.84M-$0.35N/AN/AN/AN/A-98.90%-76.31%8/8/2024 (Estimated)
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
-C$27.84M-C$1.17N/AN/A-45.81%-26.78%-3.08%8/8/2024 (Estimated)
Leaf Group Ltd. stock logo
LEAF
Leaf Group
-$8.86MN/AN/AN/A-1.94%-7.40%-3.79%N/A
Meredith Co. stock logo
MDP
Meredith
$306.60M$5.9010.01N/AN/A9.66%41.72%4.92%N/A

Latest HLS, MDP, CRDL, and LEAF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2024Q1 2024
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$0.06-$0.10-$0.04-$0.10N/AN/A
4/1/2024Q4 2023
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/A-$0.09-$0.09-$0.09N/AN/A
3/14/2024Q4 2023
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
-C$0.13-C$0.18-C$0.05-C$0.13C$21.83 millionC$21.60 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/AN/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$0.205.32%N/AN/A N/A
Leaf Group Ltd. stock logo
LEAF
Leaf Group
N/AN/AN/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
0.01
2.81
2.81
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
99.86
1.56
1.01
Leaf Group Ltd. stock logo
LEAF
Leaf Group
0.01
1.65
1.65
Meredith Co. stock logo
MDP
Meredith
4.03
1.39
1.36

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
12.49%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
59.65%
Leaf Group Ltd. stock logo
LEAF
Leaf Group
70.80%
Meredith Co. stock logo
MDP
Meredith
78.23%

Insider Ownership

CompanyInsider Ownership
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
5.25%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
0.49%
Leaf Group Ltd. stock logo
LEAF
Leaf Group
11.40%
Meredith Co. stock logo
MDP
Meredith
9.79%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/A68.37 million64.78 millionNot Optionable
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
9131.81 millionN/ANot Optionable
Leaf Group Ltd. stock logo
LEAF
Leaf Group
36036.03 millionN/AOptionable
Meredith Co. stock logo
MDP
Meredith
5,33045.78 million41.30 millionOptionable

HLS, MDP, CRDL, and LEAF Headlines

Recent News About These Companies

Medexus Pharmaceuticals Inc (MDP) NPV
What Does Meredith's Debt Look Like?
A Stock Analysis Of Meredith Corporation’s (MDP)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cardiol Therapeutics logo

Cardiol Therapeutics

NASDAQ:CRDL
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
HLS Therapeutics logo

HLS Therapeutics

TSE:HLS
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.
Leaf Group logo

Leaf Group

NYSE:LEAF
Leaf Group Ltd., together with its subsidiaries, operates as a diversified consumer internet company worldwide. It operates in two segments, Marketplaces and Media. The Marketplaces segment offers Society6.com, which provides artists with an online commerce platform to feature and sell their original art and designs on consumer products in the wall art, home décor, and tech and apparel accessories categories. It also provides SaatchiArt.com and its related art fair event brand, which is an online art gallery where a global community of artists exhibit and sell their original artwork directly to consumers. The Media segment offers Well+Good, a health and wellness media brand that offers journalistic approach to content; and Livestrong.com, a destination and action-oriented community, as well as mobile applications, such as MyPlate that monitor users' health, fitness, and life achievements. This segment also provides Hunker, a home design media site for enabling first-time homeowners enhance their homes with practical solutions, home tours, and design advice for people; and Only In Your State, a US-focused local attractions and review site, which highlights small businesses, hidden gems, and natural wonders for the audience. In addition, this segment offers content creation, traffic source, mobile application, and monetization services; and develops partner sites. It sells its products through wholesale channels to trade and hospitality clients, as well as through retail distribution partners. The company was formerly known as Demand Media, Inc. and changed its name to Leaf Group Ltd. in November 2016. Leaf Group Ltd. was incorporated in 2006 and is headquartered in Santa Monica, California.
Meredith logo

Meredith

NYSE:MDP
Meredith Corp. engages in television broadcasting and magazine advertising business. It operates through the Local Media and National Media business segments. The Local Media segment includes television stations and offers websites, mobile-optimized websites, and mobile applications. The National Media segment consists of national consumer media brands delivered via multiple media platforms including print magazines and digital and mobile media, brand licensing activities, database-related activities, and business-to-business marketing products and services. The company was founded by Edwin Thomas Meredith in 1902 and is headquartered in Des Moines, IA.